Labeler · US market
SAMSUNG BIOLOGICS Co., Ltd.
SAMSUNG BIOLOGICS Co., Ltd. is a US drug labeler with US FDA registrations covering 46 drug concepts (46 currently active) across 65 packages. It is currently the only active US supplier of 28 drugs.
ACTIVE - US
openFDA · updated weekly
Labeler codes71124
Active drugs46
Registrations58 active / 58
Packages65
Sole supplier of28 drugs
No company profile yet
FDA filings tell us what SAMSUNG BIOLOGICS Co., Ltd. registers, not who it is. If you know this company - what it makes, who owns it, where it manufactures - you can add it. Every submission is reviewed before it goes live.
Submit information about this company →Portfolio46 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Emicizumab solution | other | 4 | 4 | SUPPLYING |
| Rituximab liquid | other | 2 | 4 | SUPPLYING |
| Infliximab liquid | other | 2 | 3 | SUPPLYING |